Insights of mitochondrial involvement in alcoholic fatty liver disease
Journal of Cellular Physiology · 2023-10 · 238 (10) · 2175-2190
DOI: 10.1002/jcp.31100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 29.08.2023. Verfasst von Nithyananthan Subramaiyam. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Fatty Liver, Alcoholic, Mitochondria, Mitochondria, Liver, Liver. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Alcoholic liver disease (ALD) is a global concern affecting most of the population and leading to the development of end‐stage liver disease. Metabolic alterations due to increased alcohol consumption surge the hepatic accumulation of lipids and develop into a severe form of alcoholic steatohepatitis (ASH), depending on age and the consumption rate. The mitochondria in the hepatocyte actively regulate metabolic homeostasis and are disrupted in ALD pathogenesis. The increased NADH upon ethanol metabolism inhibits the mitochondrial oxidation of fatty acids, alters oxidative phosphorylation, and favors de novo lipogenesis. The higher mitochondrial respiration in early ALD increases free radical generation, whereas mitochondrial respiration is uncoupled in chronic ALD, affecting the cellular energy status. The defective glutathione importer due to excessive cholesterol loading and low adenosine triphosphate accounts for additional oxidative stress leading to hepatocyte apoptosis. The defective mitochondrial transcription machinery and sirtuins function in ALD affect mitochondrial function and biogenesis. The metabolites of ethanol metabolism epigenetically alter the gene expression profile of hepatic cell populations by modulating the promoters and sirtuins, aiding hepatic fibrosis and inflammation. The defect in mitophagy increases the accumulation of megamitochondria in hepatocytes and attracts immune cells by releasing mitochondrial damage‐associated molecular patterns to initiate hepatic inflammation and ASH progression. Thus, maintaining mitochondrial lipid homeostasis and antioxidant capacity pharmacologically could provide a better outcome for ALD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: Nithyananthan Subramaiyam
Zitieren
APA
Subramaiyam, N. (2023). Insights of mitochondrial involvement in alcoholic fatty liver disease. Journal of Cellular Physiology, 238(10), 2175-2190. https://doi.org/10.1002/jcp.31100
Vancouver
Subramaiyam N. Insights of mitochondrial involvement in alcoholic fatty liver disease. Journal of Cellular Physiology. 2023;238(10):2175-2190. doi:10.1002/jcp.31100
BibTeX
@article{Subramaiyam2023,
author = {Subramaiyam, Nithyananthan},
title = {Insights of mitochondrial involvement in alcoholic fatty liver disease},
journal = {Journal of Cellular Physiology},
year = {2023},
volume = {238},
number = {10},
pages = {2175--2190},
doi = {10.1002/jcp.31100}
}
EUVIMED